Skip to content

Boston Scientific BSX Payment for (Proceeds from) Other Investing Activity

Payment for (Proceeds from) Other Investing Activity at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$54M+80.0%
Stryker logo
StrykerSYK
-$1M-105%
Edwards Lifesciences logo
Edwards LifesciencesEW
$300K+400%
Abbott logo
AbbottABT
Medtronic logo
MedtronicMDT
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.4%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$67.32B-37.5%
P/E18.9×-34.3×
P/S3.3×-2.9×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForProceedsFromOtherInvestingActivities.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's payment for (proceeds from) other investing activity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's payment for (proceeds from) other investing activity?
Boston Scientific (BSX) reported payment for (proceeds from) other investing activity of -$48M in Q1 2026.
How has Boston Scientific's payment for (proceeds from) other investing activity changed year-over-year?
Boston Scientific's payment for (proceeds from) other investing activity decreased by 1500.0% year-over-year, from -$3M to -$48M.
What is the long-term trend for Boston Scientific's payment for (proceeds from) other investing activity?
Over 4 years (2021 to 2025), Boston Scientific's payment for (proceeds from) other investing activity has grown at a 0.6% compound annual growth rate (CAGR), from -$82M to -$84M.
What does payment for (proceeds from) other investing activity mean?
Cash flows from miscellaneous investing activities not classified elsewhere.
How do you interpret payment for (proceeds from) other investing activity?
Usually non-recurring; large values should be analyzed for one-time impacts on the cash position.
How does payment for (proceeds from) other investing activity compare across companies?
Typically small or infrequent; varies by company reporting structure.